144 related articles for article (PubMed ID: 8204869)
1. Cellular receptors for the plasminogen activators.
Bu G; Warshawsky I; Schwartz AL
Blood; 1994 Jun; 83(12):3427-36. PubMed ID: 8204869
[No Abstract] [Full Text] [Related]
2. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activation system and colorectal cancer biology.
Verspaget HW
Gastroenterology; 1995 Jun; 108(6):1953. PubMed ID: 7768404
[No Abstract] [Full Text] [Related]
4. Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells.
Grimsley PG; Normyle JF; Brandt RA; Joulianos G; Chesterman CN; Hogg PJ; Owensby DA
Thromb Res; 1995 Aug; 79(4):353-61. PubMed ID: 7482438
[TBL] [Abstract][Full Text] [Related]
5. The role of the pericellular fibrinolytic system in angiogenesis.
Fukao H; Ueshima S; Okada K; Matsuo O
Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
[No Abstract] [Full Text] [Related]
6. Urokinase-type plasminogen activator and its receptor in bladder cancer.
Hasui Y; Osada Y
J Natl Cancer Inst; 1997 May; 89(10):678-9. PubMed ID: 9168177
[No Abstract] [Full Text] [Related]
7. Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines.
Lyon PB; See WA; Xu Y; Cohen MB
Prostate; 1995 Oct; 27(4):179-86. PubMed ID: 7479384
[TBL] [Abstract][Full Text] [Related]
8. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
Fazioli F; Blasi F
Trends Pharmacol Sci; 1994 Jan; 15(1):25-9. PubMed ID: 8140655
[TBL] [Abstract][Full Text] [Related]
10. The urokinase-type plasminogen activator system in prostate cancer metastasis.
Sheng S
Cancer Metastasis Rev; 2001; 20(3-4):287-96. PubMed ID: 12085967
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
12. Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis.
Sier CF; Vloedgraven HJ; Ganesh S; Griffioen G; Quax PH; Verheijen JH; Dooijewaard G; Welvaart K; van de Velde CJ; Lamers CB
Gastroenterology; 1994 Nov; 107(5):1449-56. PubMed ID: 7926508
[TBL] [Abstract][Full Text] [Related]
13. The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis.
Herouy Y; Aizpurua J; Stetter C; Dichmann S; Idzko M; Hofmann C; Gitsch G; Vanscheidt W; Schöpf E; Norgauer J
J Cutan Pathol; 2001 Jul; 28(6):291-7. PubMed ID: 11401675
[TBL] [Abstract][Full Text] [Related]
14. Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator.
Magdolen V; Arroyo de Prada N; Sperl S; Muehlenweg B; Luther T; Wilhelm OG; Magdolen U; Graeff H; Reuning U; Schmitt M
Adv Exp Med Biol; 2000; 477():331-41. PubMed ID: 10849761
[No Abstract] [Full Text] [Related]
15. Tissue- and urokinase-type plasminogen activators and type 1 plasminogen activator inhibitor in melanomas and benign skin pigment neoplasms.
Gershtein ES; Medvedeva SV; Babkina IV; Kushlinskii NE; Trapeznikov NN
Bull Exp Biol Med; 2001 Jul; 132(1):670-4. PubMed ID: 11687850
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
18. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.
Jankun J; Merrick HW; Goldblatt PJ
J Cell Biochem; 1993 Oct; 53(2):135-44. PubMed ID: 8227186
[TBL] [Abstract][Full Text] [Related]
20. Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.
Krause J; Seydel W; Heinzel G; Tanswell P
Biochem J; 1990 May; 267(3):647-52. PubMed ID: 2160232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
